By www.reliableresearchiq.com
Global Fibroblast Growth Factor Receptor 3 Market Research Report 2024 Story
99
$ 2900
Fibroblast Growth Factor Receptor 3 Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Amgen Inc. ArQule, Inc. Astellas Pharma Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company CASI Pharmaceuticals Inc. Celon Pharma Sp. z o.o. Debiopharm International SA Eddingpharm